AVR
NASDAQ HealthcareAnteris Technologies Global Corp. - Common Stock
Medical Instruments & Supplies
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
�� 市场数据
| 价格 | $6.07 |
|---|---|
| 成交量 | 922,014 |
| 市值 | 590.20M |
| 贝塔系数 | 0.550 |
| RSI（14日） | 65.5 |
| 200日均线 | $4.80 |
| 50日均线 | $5.86 |
| 52周最高 | $6.95 |
| 52周最低 | $2.85 |
| Forward P/E | -6.26 |
| Price / Book | -3035.00 |
🎯 投资策略评分
AVR 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 💰 Dividend Daddy (44/100) — 此策略 高股息率 + 低波动性.
评分最低的策略： 🐋 Institutional Whale (16/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 AVR in your text
粘贴任何文章、记录或帖子 — 工具将提取 AVR 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.